Arvinas Inc (NASDAQ: ARVN) is -8.74% lower on its value in year-to-date trading and has touched a low of $15.53 and a high of $49.76 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The ARVN stock was last observed hovering at around $16.52 in the last trading session, with the day’s gains setting it 0.98%.
Currently trading at $17.50, the stock is -2.28% and -3.91% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.21 million and changing 5.90% at the moment leaves the stock -28.01% off its SMA200. ARVN registered -63.01% loss for a year compared to 6-month loss of -33.12%.
The stock witnessed a 2.31% gain in the last 1 month and extending the period to 3 months gives it a -34.52%, and is 2.07% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.29% over the week and 8.19% over the month.
Arvinas Inc (ARVN) has around 430 employees, a market worth around $1.20B and $161.00M in sales. Profit margin for the company is -92.98%. Distance from 52-week low is 12.65% and -64.84% from its 52-week high. The company has generated returns on investments over the last 12 months (-26.28%).
with sales reaching $43.5M over the same period.The EPS is expected to shrink by -41.49% this year, but quarterly earnings will post -18.91% year-over-year. Quarterly sales are estimated to grow 71.95% in year-over-year returns.
The shares outstanding are 68.80M, and float is at 59.89M with Short Float at 19.27%.
The top institutional shareholder in the company is ECOR1 CAPITAL, LLC with over 6.73 million shares valued at $179.06 million. The investor’s holdings represent 9.3553 of the ARVN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 6.67 million shares valued at $177.6 million to account for 9.2793 of the shares outstanding. The other top investors are BLACKROCK INC. which holds 6.26 million shares representing 8.7049 and valued at over $166.61 million, while PRICE T ROWE ASSOCIATES INC /MD/ holds 5.5478 of the shares totaling 3.99 million with a market value of $106.19 million.
Arvinas Inc (ARVN) Insider Activity
A total of 0 insider transactions have happened at Arvinas Inc (ARVN) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by Loomis David K, the company’s Chief Accounting Officer. SEC filings show that Loomis David K sold 1,214 shares of the company’s common stock on Feb 24 ’25 at a price of $16.75 per share for a total of $20334.0. Following the sale, the insider now owns 18863.0 shares.
Arvinas Inc disclosed in a document filed with the SEC on Feb 24 ’25 that Cacace Angela M (Chief Scientific Officer) sold a total of 4,207 shares of the company’s common stock. The trade occurred on Feb 24 ’25 and was made at $16.70 per share for $70238.0. Following the transaction, the insider now directly holds 97231.0 shares of the ARVN stock.
Still, SEC filings show that on Feb 24 ’25, Taylor Ian (President, R&D) disposed off 9,020 shares at an average price of $16.71 for $0.15 million. The insider now directly holds 159,121 shares of Arvinas Inc (ARVN).
Arvinas Inc (ARVN): Who are the competitors?
One of the company’s main competitors (and peers) include Novartis AG (NOVN) that is trading 9.82% up over the past 12 months.Roche Holding AG Akt (RO) lies in the list of competitors of the Arvinas Inc and is 27.95% higher over the same period from ARVNRogers Corp. (ROG) is -29.38% down on the 1-year trading charts.
